Spok Holdings (FQV) AI Stock Analysis
Spok Holdings
(Frankfurt:FQV)
No summary available
Spok Holdings (FQV) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 250.64M
- Dividend Yield
- 10.09%
- Average Volume (3M)
- 242
- Price to Earnings (P/E)
- 13.4
- Beta (1Y)
- 0.31
- Revenue Growth
- -8.24%
- EPS Growth
- 5.27%
- Country
- Germany
- Employees
- 415
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Healthcare Information Services
Spok Holdings Business Overview & Revenue Model
Company Description
Spok Holdings, Inc., operating primarily through its subsidiary, Spok, Inc., specializes in providing advanced communication solutions tailored for the healthcare sector. These crucial services span a wide international footprint, covering the United...
Spok Holdings Earnings Call Summary
The call balanced clear operational and financial progress (notably a 92% sequential bookings increase, record adjusted EBITDA, expense reductions, strong managed services growth, significant license revenue growth, and an $8M spectrum sale) against near‑term demand and booking dynamics (longer sales cycles, preference for shorter contract terms, slight revenue midpoint reduction, and modest wireless unit declines). Management retained the adjusted EBITDA midpoint and emphasized capital returns and continued investment in product development, signaling confidence in the company’s ability to offset revenue pressure with margin and cash generation initiatives. Overall, the tone was constructive with caution about near‑term revenue visibility.
Q2-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Management revised 2026 guidance to total revenue of $132.5M–$139.5M (midpoint $136M) and adjusted EBITDA of $28M–$32M (midpoint $30M), with wireless revenue now expected at $67M–$70M and software revenue $65.5M–$69.5M; the revenue midpoint was trimmed due to lumpiness in bookings and a pipeline where deals are taking longer and skewing to shorter/cancelable terms despite a 92% sequential jump in software operations bookings in Q2. Management said strategic realignment and cost reductions should offset revenue pressure, ARPU was stable at $8.20, Q2 license revenue was $3.6M (vs. $2.4M a year ago) and managed professional services totaled $2.3M (up 53% YoY), and they now expect to exit 2026 with $26M–$29M in cash (Q2 cash $16.6M) including a >$7M Q3 cash contribution from the $8M spectrum sale.
Spok Holdings Risk Analysis
Spok Holdings disclosed 25 risk factors in its most recent earnings report. Spok Holdings reported the most risks in the "Tech & Innovation" category.
Latest Risks Added
0 New RisksSpok Holdings Peers Comparison
Overall Rating
OPRX70Outperform
CCLD62Neutral
NRC50Neutral
HCAT47Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 70Outperform | $177.25M | 38.30 | 3.60% | ― | -5.82% | ― | |
| 62Neutral | $73.09M | 24.64 | 16.56% | ― | 15.07% | ― | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 50Neutral | $536.62M | 79.57 | 103.40% | 2.66% | 3.37% | -59.53% | |
| 47Neutral | $118.91M | -0.39 | -129.70% | ― | -7.54% | -143.41% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:FQV | Spok Holdings | 10.70 | 0.07 | 0.65% | |
| OPRX | Optimizerx Corporation | 9.33 | -9.83 | -51.30% | |
| CCLD | Carecloud, Inc. | 1.72 | -1.23 | -41.69% | |
| NRC | National Research | 24.07 | 10.46 | 76.89% | |
| HCAT | Health Catalyst | 1.44 | -1.61 | -52.79% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.